Simplifying Global Compliance
FDAnews Drug Daily Bulletin
Pfizer Sues Alembic Over Lyrica ANDA
Dec. 12, 2011
Pfizer and Northwestern University launched a suit in Delaware federal court accusing Alembic of infringing a patent for nerve pain drug Lyrica by seeking approval to sell a generic version of the drug.
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing